Using a single inhaler device containing an inhaled corticosteroid plus a long-acting β-adrenoceptor agonist is a practical approach in patients with moderate to severe asthma

被引：0
|
作者：
机构：
来源：
Drugs & Therapy Perspectives | 2008年 / 24卷 / 3期
关键词：
Asthma; Salmeterol; Formoterol; Nedocromil; Zafirlukast;
D O I：
10.2165/00042310-200824030-00003
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：9 / 11
页数：2
相关论文
共 50 条
  • [1] INHALED CORTICOSTEROID AND LONG-ACTING BETA-AGONIST MEDICATION COMPLIANCE IN PATIENTS WITH MODERATE AND SEVERE ASTHMA
    Guo, J. J.
    Kelton, C. M.
    Tsai, K.
    Cai, B.
    Bian, B.
    Wigle, P. R.
    VALUE IN HEALTH, 2012, 15 (04) : A57 - A57
  • [2] Which inhaled corticosteroid and long-acting β-agonist combination is better in patients with moderate-to-severe asthma, a dry powder inhaler or a pressurized metered-dose inhaler?
    Muraki, Masato
    Gose, Kyuya
    Hanada, Soichiro
    Sawaguchi, Hirochiyo
    Tohda, Yuji
    DRUG DELIVERY, 2017, 24 (01) : 1395 - 1400
  • [3] Randomized controlled trial of adherence with single or combination inhaled corticosteroid/long-acting β-agonist inhaler therapy in asthma
    Perrin, Kyle
    Williams, Mathew
    Wijesinghe, Meme
    James, Kate
    Weatherall, Mark
    Beasley, Richard
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2010, 126 (03) : 505 - 510
  • [4] Open-inhaler versus single-inhaler triple therapy (long-acting muscarinic antagonist, inhaled corticosteroid, and long-acting β2-agonist) in asthma patients: a narrative review
    Wechsler, Michael E.
    Oppenheimer, John J.
    JOURNAL OF ASTHMA, 2023, 60 (09) : 1633 - 1645
  • [5] An assessment of asthma exacerbations in pediatric patients using a long-acting B2-agonist plus inhaled corticosteroid versus an inhaled corticosteroid alone
    Alakeel, Yousif S.
    Khader, Esraa
    Altuwayli, Norah
    Alrammah, Shahad
    Abdel-Razaq, Wesam
    SAUDI PHARMACEUTICAL JOURNAL, 2022, 30 (03) : 300 - 305
  • [6] Combination inhaled corticosteroid and long-acting β2-agonist use and severe asthma exacerbations
    Pedersen, Soren
    O'Byrne, Paul M.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2012, 129 (05) : 1280 - 1281
  • [7] APPROPRIATE USE OF INHALED CORTICOSTEROID AND LONG-ACTING β-AGONIST COMBINATION THERAPY AMONG ASTHMA PATIENTS
    Blanchette, C. M.
    Culler, S.
    Gutierrez, B.
    VALUE IN HEALTH, 2009, 12 (03) : A128 - A128
  • [8] Differential effects of maintenance long-acting β-agonist and inhaled corticosteroid on asthma control and asthma exacerbations
    Gibson, Peter G.
    Powell, Heather
    Ducharme, Francine M.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2007, 119 (02) : 344 - 350
  • [9] Comparison of pneumonia incidence between long-acting muscarinic antagonist and inhaled corticosteroid plus long-acting beta agonist in patients with COPD
    Eung Gu Lee
    Youlim Kim
    Yong Il Hwang
    Kwang Ha Yoo
    So Eun Lee
    Kyung Yoon Jung
    Doik Lee
    Yong Bum Park
    Chin Kook Rhee
    Scientific Reports, 13
  • [10] Comparison of pneumonia incidence between long-acting muscarinic antagonist and inhaled corticosteroid plus long-acting beta agonist in patients with COPD
    Lee, Eung Gu
    Kim, Youlim
    Hwang, Yong Il
    Yoo, Kwang Ha
    Lee, So Eun
    Jung, Kyung Yoon
    Lee, Doik
    Park, Yong Bum
    Rhee, Chin Kook
    SCIENTIFIC REPORTS, 2023, 13 (01)
12345